Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Fesco opened a subsidiary in Vietnam

12/18/24 FESH

Novoship's Board of Directors recommends dividends

12/18/24 NOMP

T-Bank and Rosbank's RAS profit for 11 months increased by 60%

12/18/24 T

T-Investments launched a line of investment instruments on blockchain

12/18/24 T

MTS is spinning off its IT business into a separate company

12/18/24 MTSS

Moscow Exchange launched SAPFIR trading and clearing system

12/17/24 MOEX

Fix Price launched delivery in Belarus

12/17/24 FIXP

MD Medical opened a new clinic in Moscow

12/17/24 MDMG

Delimobile will launch a car repair business line

12/17/24 DELI

Ozon and SDEK started opening joint PVZ

12/17/24 OZON